Richard Harris

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington (DC) Star.

Harris is co-founder of the Washington, D.C., Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

Pages

Shots - Health News
3:00 pm
Thu December 11, 2014

Unexpected Joint Pain Seen In Test Of Experimental Ebola Vaccine

A shipment of experimental Ebola vaccine is opened at a hospital in Geneva.
Mathilde Missioneiro AP

Two potential Ebola vaccines are currently being tested in people, to see if they're safe and to figure out the best dose.

Both trials have encountered some of the typical travails of vaccine research.

Read more
Shots - Health News
3:54 am
Wed December 10, 2014

Scientists Often Skip A Simple Test That Could Verify Their Work

When the wrong cells take over, scientists' experiments can be derailed.
Chris Nickels for NPR

Originally published on Wed December 10, 2014 4:34 pm

There's a simple test that scientists could use to make sure the cells they're studying in the lab are what they think they are. But most of the time, academic scientists don't bother.

That omission is a problem. One study found that between 18 percent and 36 percent of all cell lines have been misidentified. And this kind of mistaken identity is one reason that many results from experiments run in scientific labs can't be reproduced elsewhere.

Read more
Shots - Health News
4:11 am
Tue December 9, 2014

Mistaken Identities Plague Lab Work With Human Cells

Georgetown's Robert Clark says it's very difficult to say precisely how many experiments have been spoiled by contaminated cell lines.
Phil Humnicky Courtesy of Georgetown University

Originally published on Wed December 17, 2014 6:55 pm

There's a major flaw in many medical research studies that seems so basic that you'd think scientists would be smart enough to avoid it.

It turns out that cells studied in the laboratory often get mixed up. A researcher who thinks she is studying breast cancer cells might in fact be using melanoma cells.

It's a surprisingly common problem — even in some of the top scientific labs.

Read more
Shots - Health News
10:26 am
Tue November 25, 2014

How Can Vultures Eat Rotten Roadkill And Survive?

Originally published on Wed November 26, 2014 2:31 pm

You might wonder why 48 million Americans get food poisoning every year, yet there are some animals that seem to be immune from even the nastiest germs.

We're talking here about vultures, which feast on rotting flesh that is chockablock with bacteria that would be deadly to human beings. In fact, vultures have a strong preference for that kind of food.

Read more
Shots - Health News
11:01 am
Mon November 24, 2014

Merck Partners With NewLink To Speed Up Work On Ebola Vaccine

A 26-year-old man receives an injection in September of an experimental Ebola vaccine being tested by the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline.
NIAID

It's now Goliath versus Goliath in the quest for an Ebola vaccine.

Until now, the two leading candidates for a vaccine to protect against the Ebola virus were being led by global pharmaceutical giant GlaxoSmithKline on the one hand, and a tiny company in Ames, Iowa, that was virtually unknown, on the other.

Read more
Global Health
4:13 am
Thu November 13, 2014

Swiss Health Officials Try New Ways To Combat Ebola

Originally published on Thu November 13, 2014 6:54 am

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

DAVID GREENE, HOST:

Read more
Goats and Soda
2:35 am
Tue November 11, 2014

Medical Experts Look For New Ways To Test Ebola Drugs

Nurses assist a new patient at an Ebola center in Liberia's Lofa County. As drug trials get underway, patients may receive experimental medicines.
Tommy Trenchard NPR

Originally published on Tue November 11, 2014 7:06 am

Medical experts are meeting today and tomorrow at the World Health Organization in Geneva to figure out how to test potential Ebola drugs in Africa. In addition to determining which experimental drugs should be the highest priority, the experts are sorting through some difficult ethical issues.

In short, they're trying to figure out how to design tests that will provide the fastest and most trustworthy answers — and yet minimize the need for comparison groups who won't be offered the experimental treatments.

Read more
Shots - Health News
3:21 pm
Tue October 28, 2014

Blood Test For Ebola Doesn't Catch Infection Early

Magnified 25,000 times, this digitally colorized scanning electron micrograph shows Ebola virus particles (green) budding from an infected cell (blue).
CDC/NIAD

Originally published on Wed October 29, 2014 7:48 am

In an ideal world, health care workers returning from West Africa would get a quick blood test to prove they aren't carrying the Ebola virus. A test like that would likely put to rest some of the anxiety surrounding these doctors, nurses and scientists.

Unfortunately, even the best blood test in the world can't do that.

The test uses a technology called PCR, for polymerase chain reaction. It can detect extraordinarily small traces of genetic material from the Ebola virus.

Read more
Shots - Health News
5:19 pm
Tue October 21, 2014

Ebola Vaccine Could Start Testing In Africa By January

Patients in a clinic line up to get a smallpox shot on Feb. 24, 1962, in Leopoldville, Congo. Health workers used vaccination campaigns to finally eradicate smallpox by 1980.
AP

Originally published on Wed October 22, 2014 9:22 am

The World Health Organization says that efforts are on track to distribute an experimental Ebola vaccine in West Africa in January.

Two potential vaccines are now being tested for safety in people, and Russia is developing another one. While quantities will be limited, scientists say even a relatively small supply of vaccine can help bring the epidemic under control.

Read more
Global Health
4:44 pm
Mon October 6, 2014

Dallas Ebola Patient Receives Experimental Drug

Originally published on Mon October 6, 2014 5:30 pm

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

MELISSA BLOCK, HOST:

Read more

Pages